Atom Bioworks
Atom Bioworks is a biotechnology company focused on accelerating drug discovery and development through advanced AI. Their core offering is the AptaBLE platform, a generative AI tool designed to rapidly discover and optimize aptamers, which are synthetic nucleic acid molecules that can bind to specific protein targets with high affinity and specificity. AptaBLE aims to overcome the limitations of traditional aptamer discovery methods (SELEX), offering faster development cycles, improved nuclease resistance, and reduced off-target effects compared to existing AI tools like AlphaFold for this specific application. The company also utilizes aptamer technology for cell type-specific drug delivery, particularly with AptLNP for genetic medicine, aiming to target extrahepatic tissues. Atom Bioworks has been recognized for its work, presenting at NeurIPS 2024 and joining programs like Google Cloud for Startups and NVIDIA Inception.
Atom Bioworks
Atom Bioworks is a biotechnology company focused on accelerating drug discovery and development through advanced AI. Their core offering is the AptaBLE platform, a generative AI tool designed to rapidly discover and optimize aptamers, which are synthetic nucleic acid molecules that can bind to specific protein targets with high affinity and specificity. AptaBLE aims to overcome the limitations of traditional aptamer discovery methods (SELEX), offering faster development cycles, improved nuclease resistance, and reduced off-target effects compared to existing AI tools like AlphaFold for this specific application. The company also utilizes aptamer technology for cell type-specific drug delivery, particularly with AptLNP for genetic medicine, aiming to target extrahepatic tissues. Atom Bioworks has been recognized for its work, presenting at NeurIPS 2024 and joining programs like Google Cloud for Startups and NVIDIA Inception.